SMNR (Semnur Pharmaceuticals) FCF Margin %: 0.00% (As of Mar. 2026)


SMNR Semnur Pharmaceuticals Inc SMNR
8 GF Score
Price $0.71
View Full Analysis

What is Semnur Pharmaceuticals FCF Margin %?

Semnur Pharmaceuticals SMNR +9.23% 8 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates SMNR with a GF Score™ of 8/100. Among 948 Biotechnology companies, Semnur Pharmaceuticals ranks worse than 105485.13% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Semnur Pharmaceuticals's Free Cash Flow for the three months ended in Mar. 2026 was $-2.67 Mil. Semnur Pharmaceuticals's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Semnur Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Semnur Pharmaceuticals's current FCF Yield % is -4.98%.

The historical rank and industry rank for Semnur Pharmaceuticals's FCF Margin % or its related term are showing as below:


SMNR's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -81.28
* Ranked among companies with meaningful FCF Margin % only.

Semnur Pharmaceuticals FCF Margin % Related Terms

Semnur Pharmaceuticals FCF Margin % Historical Data

* Premium members only.

The historical data trend for Semnur Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Semnur Pharmaceuticals FCF Margin % Chart

Semnur Pharmaceuticals Annual Data
Trend Dec22 Dec23 Dec24 Dec25
FCF Margin %
0.00 0.00 0.00 0.00

Semnur Pharmaceuticals Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SMNR vs CNTB, ENLV, MENS: FCF Margin % Comparison

For the Biotechnology subindustry, Semnur Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Semnur Pharmaceuticals FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Semnur Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Semnur Pharmaceuticals's FCF Margin % falls into.


SMNR
8GF Score
Semnur Pharmaceuticals Inc SMNR
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Semnur Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Semnur Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-5.867/0
= %

Semnur Pharmaceuticals's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-2.67/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Semnur Pharmaceuticals (SMNR) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Semnur Pharmaceuticals and its competitors. According to the industry distribution chart, Semnur Pharmaceuticals ranks #999999 out of 948 companies in the Biotechnology industry.
Is Semnur Pharmaceuticals' FCF Margin % too high?
Semnur Pharmaceuticals' current FCF Margin % is 0.00%. Based on the distribution chart, Semnur Pharmaceuticals ranks #999999 out of 948 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Semnur Pharmaceuticals has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Semnur Pharmaceuticals' FCF Margin % compare to CNTB and ENLV?
According to the Biotechnology industry distribution chart, Semnur Pharmaceuticals ranks #999999 out of 948 companies for FCF Margin %. This places Semnur Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Semnur Pharmaceuticals and its competitors. Semnur Pharmaceuticals's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Semnur Pharmaceuticals stock overvalued right now?
Semnur Pharmaceuticals (SMNR) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Semnur Pharmaceuticals' overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Semnur Pharmaceuticals (SMNR), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Semnur Pharmaceuticals Business Description

Address 960 San Antonio Road, Palo Alto, CA, USA, 94303
Semnur Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its main product candidate, SP-102 (10 mg, dexamethasone sodium phosphate viscous gel), is being developed as a non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe LRP (also known as sciatica), containing no preservatives, surfactants, solvents, or particulates.
8GF Score

Get the complete analysis for SMNR

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.71
Price